Scandinavian Airline SAS Files for Bankruptcy Protection 

The carrier has filed for bankruptcy protection in the U.S., saying a move by about 1,000 of its pilots to go on strike would worsen its already fraught finances.

CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn't Spared. 

CureVac says its intellectual property portfolio protects multiple inventions that are considered essential to Pfizer and BioNTech's Covid-19 vaccine.

Blackstone Bets on Global Tourism Boom With Australian Resort Deal 

As Covid-19 cases have fallen and international air travel has increased, some resorts are benefiting.

Amazon, Microsoft, Google Strengthen Grip on Cloud 

The three companies account for about two-thirds of cloud spending and are using their size to maintain their hold on the rapidly growing market.

China's Big Airbus Order Isn't an All-Clear for Airline Stocks 

The big three Chinese carriers have just placed their first significant order since the pandemic began. But all isn't well just yet: There are still some obvious squalls brewing.

Sanctions Threaten Russia's Next Huge Oil Field 

Vostok Oil, a vast patch in Russia's far north, faces setbacks as Western sanctions impede its access to cash and technology.

New Zealand Treasury Bars The Wall Street Journal From Restricted Briefings Until 2025 

New Zealand's Treasury will bar The Wall Street Journal from attending restricted briefings for three years for publishing budget information before the scheduled release time in May.

Smaller Companies Are Urged to Adopt Multifactor Authentication 

Too many small and medium-size businesses rely on usernames and passwords alone to secure their systems, leaving them vulnerable to cyberattacks that could otherwise be prevented, government officials and cybersecurity chiefs say.

Private-Equity Firms Poach Talent to Chase Wealthy Investors 

Alternative-asset managers are furiously hiring investment advisers and marketers as they seek to raise capital from individual investors.

Little-Known Abortion Pill Maker Faces Scrutiny 

The debate over medication abortions draws in the lone U.S. manufacturer of brand-name mifepristone.


(END) Dow Jones Newswires

July 05, 2022 09:15 ET (13:15 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.